Latest Strategy News

Classic Minerals has restated its 80% beneficial interest in the Forrestania Gold Project, emphasizing that recent acquisitions by Forrestania Resources do not affect its rights, which remain protected amid ongoing Supreme Court litigation.

Viridis Mining has delivered strong infill drilling results at its Colossus Rare Earth Project, boosting resource confidence and underpinning an imminent resource and reserve upgrade ahead of a Final Investment Decision in Q3 2026.

Vicinity Centres has secured Eastern Creek Quarter, a hybrid retail hub in Western Sydney, for $400 million, boosting its metropolitan Sydney presence and outlet network.

Kincora Copper has accelerated exploration across its Australian and Mongolian assets, leveraging new AI and quantum technology partnerships alongside partner-funded drilling, while reporting a modest net income and a strong cash position in Q1 2026.

Toubani Resources has locked in a binding commitment for a US$73.3 million senior debt facility from Coris Bank to fund its Kobada Gold Mine construction, advancing its financing package amid strong cash reserves.

AVITA Medical reported a 4% revenue increase in Q1 2026 with a narrowed net loss, underpinned by a new BARDA contract and promising Cohealyx clinical data. Leadership changes and regulatory approvals support a confident outlook.

Australian Oil Company Limited has completed its first crude oil lifting from the Emu Apple Oil Field, marking a key step in its Surat Basin development with steady production and active exploration underway.

Pacific Edge edges closer to a Medicare breakthrough with a draft Local Coverage Determination proposing coverage for its Cxbladder Triage and Triage Plus tests, potentially unlocking reimbursement for over 66 million US patients.

Catalina Resources has secured a significant portfolio of gold and base metal projects in Western Australia's Mid-West and Lake Johnston regions, backed by a $3 million capital raise to accelerate exploration and development.

Lumos Diagnostics has reached a key enrolment milestone in its BARDA-backed FebriDx paediatric trial, unlocking a US$670,000 payment and advancing its FDA submission pathway to expand use in children aged 2-12 years.

Despite sweeping changes to Capital Gains Tax announced in the 2026/27 Federal Budget, Acrux Limited’s status as a Pooled Development Fund ensures its shareholders remain shielded from these new tax rules.

Locksley Resources has secured an option to acquire the Iron Duke Copper & Gold Project in NSW, enhancing its district-scale strategy near Tottenham with high-grade mineralisation and multiple drill-ready targets.